← back to search

Dirk C. Hoffmann

German Cancer Research Center · DE
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Glioma Diagnosis and Treatment, Microtubule and mitosis dynamics, Protein Kinase Regulation and GTPase Signaling, and Lymphoma Diagnosis and Treatment.
h-index
16
citations
1,551
works
66
NIH funding
primary concept
Biology
email

Recent publications

Decoding Plasticity Regulators and Transition Trajectories in Glioblastoma with Single-cell Multiomics
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 10position: middledoi
Development of a fully human glioblastoma-in-brain-spheroid model for accelerated translational research
Journal of Advanced Research 2025cited by 5position: middledoi
Molecular recording of cellular protein kinase activity with chemical labeling
Nature Chemical Biology 2025cited by 5position: middledoi
Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen
Journal of Neurology 2025cited by 4position: middledoi
Innovative Therapeutic Strategies Targeting the Network Architecture of Glioblastoma
Clinical Cancer Research 2025cited by 4position: middledoi
Screening for Tumor Microtube–Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression
Cancer Discovery 2025cited by 2position: middledoi
Recording physiological history of cells with chemical labeling
Science 2024cited by 65position: middledoi
PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma
BMC Cancer 2024cited by 46position: middledoi
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1
Nature Communications 2024cited by 45position: middledoi
Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System Glioma
Clinical Cancer Research 2024cited by 24position: middledoi
Clinical Presentation, Management, and Outcome in Neurolymphomatosis
Neurology 2024cited by 17position: middledoi
Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models
Journal of Neuro-Oncology 2024cited by 12position: middledoi
Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas
Neuro-Oncology 2024cited by 5position: middledoi
Molecular recording of cellular protein kinase activity with chemical labeling
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 2position: middledoi
CNSC-27. INTRATUMORAL CANCER CELL NETWORKS IN BRAIN METASTASES
Neuro-Oncology 2024cited by 1position: middledoi
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression
Neuro-Oncology 2023cited by 51position: middledoi
Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas
Acta Neuropathologica 2023cited by 20position: middledoi
NLGN4X TCR transgenic T cells to treat gliomas
Neuro-Oncology 2023cited by 15position: middledoi
Abstract 1084: AI-aided drug development for disconnecting glioma tumor microtube networks
Cancer Research 2023cited by 1position: middledoi
Glioblastoma hijacks neuronal mechanisms for brain invasion
Cell 2022cited by 586position: middledoi
Autonomous rhythmic activity in glioma networks drives brain tumour growth
Nature 2022cited by 242position: middledoi
AAMP is a binding partner of costimulatory human B7-H3
Neuro-Oncology Advances 2022cited by 16position: middledoi
A connectivity signature for glioblastoma
WFNOS 2022 Abstract Book 2022cited by 1position: middledoi
Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma
Nature Communications 2021cited by 151position: middledoi
The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis
Neuro-Oncology 2021cited by 90position: middledoi
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Journal of Neurochemistry 2021cited by 43position: middledoi
Radioresistance and Transcriptional Reprograming of Invasive Glioblastoma Cells
International Journal of Radiation Oncology*Biology*Physics 2021cited by 18position: middledoi
A connectivity signature for glioblastoma
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 10position: middledoi
BSCI-11. Targeting PI3K/Akt/mTOR pathway to prevent melanoma brain metastasis
Neuro-Oncology Advances 2021cited by 3position: middledoi
Tumor cell network integration in glioma represents a stemness feature
Neuro-Oncology 2020cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wolfgang Wick · Heidelberger Institut für Radioonkologie24 papers (2020–2025)Frank Winkler · TU Dresden18 papers (2020–2025)Tobias Keßler · German Cancer Research Center13 papers (2020–2025)Felix Sahm · Heidelberg (Poland)9 papers (2020–2024)Daniel Domínguez Azorín · The Geneva Association8 papers (2021–2025)Erik Jung · German Cancer Research Center7 papers (2020–2025)Miriam Ratliff · German Cancer Research Center7 papers (2020–2025)Ling Hai · Mongolian National University of Medical Sciences6 papers (2020–2025)Matthias Schlesner · University of Augsburg5 papers (2020–2024)Sophie Weil · Heidelberg University5 papers (2021–2025)Varun Venkataramani · DKFZ-ZMBH Alliance5 papers (2020–2024)Ruifan Xie · Heidelberg University5 papers (2020–2022)Andreas von Deimling · Stiftung Schleswig-Holsteinische Landesmuseen4 papers (2020–2022)David Hausmann · German Cancer Research Center4 papers (2023–2025)Henriette Mandelbaum · Universitätsklinikum Erlangen4 papers (2020–2023)Ling Hai · German Cancer Research Center4 papers (2023–2025)Matthia A. Karreman · Heidelberg University4 papers (2021–2024)Christel Herold‐Mende · German Cancer Research Center4 papers (2021–2024)Leon D. Kaulen · German Cancer Research Center3 papers (2023–2024)Philipp Kickingereder · University of Bonn3 papers (2020–2024)